title: Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats.
abstract: Altered glutamate signaling is associated with Parkinson's disease. To study the involvement of the cystine/glutamate antiporter in the pathogenesis of Parkinson's disease, we developed new polyclonal antibodies recognizing xCT, the specific subunit of this antiporter. The striatal xCT protein expression level was investigated in a hemi-Parkinson rat model, using semiquantitative western blotting. We observed time-dependent changes after a unilateral 6-hydroxydopamine lesion of the nigrostriatal pathway with increased expression levels in the deafferented striatum after 3 weeks. Twelve weeks postlesion, expression levels returned to normal. These data suggest, for the first time, an involvement of the cystine/glutamate antiporter in determining the aberrant glutamate neurotransmission in the striatum of a parkinsonian brain.
authors.affiliation: Department of Pharmaceutical Chemistry and Drug Analysis, Research Group Experimental Pharmacology, Vrije Universiteit Brussel, Brussels, Belgium.
authors.forename: Ann
authors.initials: A
authors.lastname: Massie
authors.forename: Anneleen
authors.initials: A
authors.lastname: Schallier
authors.forename: Birgit
authors.initials: B
authors.lastname: Mertens
authors.forename: Katia
authors.initials: K
authors.lastname: Vermoesen
authors.forename: Shiro
authors.initials: S
authors.lastname: Bannai
authors.forename: Hideyo
authors.initials: H
authors.lastname: Sato
authors.forename: Ilse
authors.initials: I
authors.lastname: Smolders
authors.forename: Yvette
authors.initials: Y
authors.lastname: Michotte
mesh_terms: D027182:Amino Acid Transport System y+ / Q000378:metabolism*; D000818:Animals; D015153:Blotting, Western; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D004195:Disease Models, Animal; D004797:Enzyme-Linked Immunosorbent Assay; D007274:Injections, Intraperitoneal; D008297:Male; D008474:Medial Forebrain Bundle / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D051379:Mice; D018345:Mice, Knockout; D016627:Oxidopamine / Q000008:administration & dosage / Q000633:toxicity; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar; D013378:Substantia Nigra / Q000187:drug effects / Q000378:metabolism*; D013997:Time Factors
chemical_list: D027182:Amino Acid Transport System y+; C492255:Slc7a11 protein, mouse; D016627:Oxidopamine